Literature DB >> 24634327

Joint modeling of survival and longitudinal non-survival data: current methods and issues. Report of the DIA Bayesian joint modeling working group.

A Lawrence Gould1, Mark Ernest Boye2, Michael J Crowther3, Joseph G Ibrahim4, George Quartey5, Sandrine Micallef6, Frederic Y Bois7,8.   

Abstract

Explicitly modeling underlying relationships between a survival endpoint and processes that generate longitudinal measured or reported outcomes potentially could improve the efficiency of clinical trials and provide greater insight into the various dimensions of the clinical effect of interventions included in the trials. Various strategies have been proposed for using longitudinal findings to elucidate intervention effects on clinical outcomes such as survival. The application of specifically Bayesian approaches for constructing models that address longitudinal and survival outcomes explicitly has been recently addressed in the literature. We review currently available methods for carrying out joint analyses, including issues of implementation and interpretation, identify software tools that can be used to carry out the necessary calculations, and review applications of the methodology.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  applications; random effects; software; time-dependent

Mesh:

Substances:

Year:  2014        PMID: 24634327      PMCID: PMC4677775          DOI: 10.1002/sim.6141

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  48 in total

1.  Joint modelling of longitudinal measurements and event time data.

Authors:  R Henderson; P Diggle; A Dobson
Journal:  Biostatistics       Date:  2000-12       Impact factor: 5.899

2.  Joint modeling of longitudinal outcomes and survival using latent growth modeling approach in a mesothelioma trial.

Authors:  Ping Wang; Wei Shen; Mark Ernest Boye
Journal:  Health Serv Outcomes Res Methodol       Date:  2012-06-05

Review 3.  A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples.

Authors:  Robert J Bauer; Serge Guzy; Chee Ng
Journal:  AAPS J       Date:  2007-03-02       Impact factor: 4.009

Review 4.  Reporting on quality of life in randomised controlled trials: bibliographic study.

Authors:  C Sanders; M Egger; J Donovan; D Tallon; S Frankel
Journal:  BMJ       Date:  1998-10-31

5.  Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach.

Authors:  C L Faucett; D C Thomas
Journal:  Stat Med       Date:  1996-08-15       Impact factor: 2.373

6.  A Bayesian semiparametric multivariate joint model for multiple longitudinal outcomes and a time-to-event.

Authors:  Dimitris Rizopoulos; Pulak Ghosh
Journal:  Stat Med       Date:  2011-02-21       Impact factor: 2.373

7.  Bayesian inference on joint models of HIV dynamics for time-to-event and longitudinal data with skewness and covariate measurement errors.

Authors:  Yangxin Huang; Getachew Dagne; Lang Wu
Journal:  Stat Med       Date:  2011-07-31       Impact factor: 2.373

8.  Modelling progression of CD4-lymphocyte count and its relationship to survival time.

Authors:  V De Gruttola; X M Tu
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

9.  Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex.

Authors:  V De Gruttola; M Wulfsohn; M A Fischl; A Tsiatis
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-04

10.  CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use.

Authors:  J M Taylor; J L Fahey; R Detels; J V Giorgi
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989
View more
  45 in total

1.  Impact of Abstinence and of Reducing Illicit Drug Use Without Abstinence on Human Immunodeficiency Virus Viral Load.

Authors:  Robin M Nance; Maria Esther Perez Trejo; Bridget M Whitney; Joseph A C Delaney; Fredrick L Altice; Curt G Beckwith; Geetanjali Chander; Redonna Chandler; Katerina Christopoulous; Chinazo Cunningham; William E Cunningham; Carlos Del Rio; Dennis Donovan; Joseph J Eron; Rob J Fredericksen; Shoshana Kahana; Mari M Kitahata; Richard Kronmal; Irene Kuo; Ann Kurth; W Chris Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Lawrence J Ouellet; Vu M Quan; Michael S Saag; Jane M Simoni; Sandra Springer; Lauren Strand; Faye Taxman; Jeremy D Young; Heidi M Crane
Journal:  Clin Infect Dis       Date:  2020-02-14       Impact factor: 9.079

2.  Integrating Quality of Life and Survival Outcomes in Cardiovascular Clinical Trials.

Authors:  Jacob V Spertus; Laura A Hatfield; David J Cohen; Suzanne V Arnold; Martin Ho; Philip G Jones; Martin Leon; Bram Zuckerman; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-06-13

3.  A new method for analysing transition to psychosis: Joint modelling of time-to-event outcome with time-dependent predictors.

Authors:  Hok Pan Yuen; Andrew Mackinnon; Barnaby Nelson
Journal:  Int J Methods Psychiatr Res       Date:  2017-09-24       Impact factor: 4.035

4.  A joint model for mixed and truncated longitudinal data and survival data, with application to HIV vaccine studies.

Authors:  Tingting Yu; Lang Wu; Peter B Gilbert
Journal:  Biostatistics       Date:  2018-07-01       Impact factor: 5.899

5.  Survival analysis with time-dependent covariates subject to missing data or measurement error: Multiple Imputation for Joint Modeling (MIJM).

Authors:  Margarita Moreno-Betancur; John B Carlin; Samuel L Brilleman; Stephanie K Tanamas; Anna Peeters; Rory Wolfe
Journal:  Biostatistics       Date:  2018-10-01       Impact factor: 5.899

6.  Development and performance of npde for the evaluation of time-to-event models.

Authors:  M Cerou; M Lavielle; K Brendel; M Chenel; E Comets
Journal:  Pharm Res       Date:  2018-01-09       Impact factor: 4.200

7.  Brief Report: Reduced Use of Illicit Substances, Even Without Abstinence, Is Associated With Improved Depressive Symptoms Among People Living With HIV.

Authors:  Joseph A Delaney; Robin M Nance; Bridget M Whitney; Frederick L Altice; Xinyuan Dong; Maria Esther Perez Trejo; Mika Matsuzaki; Faye S Taxman; Geetanjali Chander; Irene Kuo; Rob Fredericksen; Lauren N Strand; Joseph J Eron; Elvin Geng; Mari M Kitahata; William C Mathews; Kenneth Mayer; Richard D Moore; Michael S Saag; Sandra Springer; Redonna Chandler; Shoshana Kahana; Heidi M Crane
Journal:  J Acquir Immune Defic Syndr       Date:  2018-11-01       Impact factor: 3.731

8.  Associations between community-level disaster exposure and individual-level changes in disability and risk of death for older Americans.

Authors:  Samuel L Brilleman; Rory Wolfe; Margarita Moreno-Betancur; Anne E Sales; Kenneth M Langa; Yun Li; Elizabeth L Daugherty Biddison; Lewis Rubinson; Theodore J Iwashyna
Journal:  Soc Sci Med       Date:  2016-12-05       Impact factor: 4.634

9.  HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study.

Authors:  Robin M Nance; J A Chris Delaney; Jane M Simoni; Ira B Wilson; Kenneth H Mayer; Bridget M Whitney; Frances M Aunon; Steven A Safren; Michael J Mugavero; W Christopher Mathews; Katerina A Christopoulos; Joseph J Eron; Sonia Napravnik; Richard D Moore; Benigno Rodriguez; Bryan Lau; Rob J Fredericksen; Michael S Saag; Mari M Kitahata; Heidi M Crane
Journal:  Ann Intern Med       Date:  2018-08-21       Impact factor: 25.391

10.  Time-varying Hazards Model for Incorporating Irregularly Measured, High-Dimensional Biomarkers.

Authors:  Xiang Li; Quefeng Li; Donglin Zeng; Karen Marder; Jane Paulsen; Yuanjia Wang
Journal:  Stat Sin       Date:  2020-07       Impact factor: 1.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.